BACKGROUND: With the growing population of HIV-exposed uninfected (HEU) children globally, it is important to determine population-level growth differences between HEU and HIV-unexposed uninfected (HUU) children. METHODS: We analyzed data from a population-level survey enrolling mother-infant pairs attending 6-week and 9-month immunizations in 140 clinics across Kenya. Weight-for-age (WAZ), length-for-age (LAZ), head circumference-for-age (HCAZ) z-scores and underweight (WAZ < -2), stunting (LAZ < -2), and microcephaly (HCAZ < -2), were compared between HEU and HUU. Correlates of growth faltering and poor growth were assessed using generalized Poisson and linear regression models. RESULTS: Among 2457 infants, 456 (19%) were HEU. Among mothers living with HIV, 64% received antiretroviral therapy (ART) and 22% were on antiretroviral prophylaxis during pregnancy. At 9 months, 72% of HEU and 98% of HUU were breastfeeding. At 6 weeks, HEU had lower mean WAZ (-0.41 vs. -0.09; P < 0.001) and LAZ (-0.99 vs. -0.31; P = 0.001) than HUU. Stunting was higher in HEU than HUU at 6 weeks (34% vs. 18%, P < 0.001) and 9 months (20% vs. 10%, P < 0.001). In multivariable analyses, HEU had lower mean LAZ at 6 weeks (-0.67, 95% confidence interval [CI]: -1.07, -0.26) and 9 months (-0.57, 95% CI: -0.92, -0.21) and HEU had higher stunting prevalence (week-6 adjusted prevalence ratio [aPR]: 1.88, 95% CI: 1.35, 2.63; month-9 aPR: 2.10, 95% CI: 1.41, 3.13). HEU had lower mean head circumference (-0.49, 95% CI: -0.91, -0.07) and higher prevalence of microcephaly (aPR: 2.21, 95% CI: 1.11, 4.41) at 9 months. CONCLUSION: Despite high maternal ART coverage, HEU had poorer growth than HUU in this large population-level comparison. Optimizing breastfeeding practices in HEU may be useful to improve growth.
BACKGROUND: With the growing population of HIV-exposed uninfected (HEU) children globally, it is important to determine population-level growth differences between HEU and HIV-unexposed uninfected (HUU) children. METHODS: We analyzed data from a population-level survey enrolling mother-infant pairs attending 6-week and 9-month immunizations in 140 clinics across Kenya. Weight-for-age (WAZ), length-for-age (LAZ), head circumference-for-age (HCAZ) z-scores and underweight (WAZ < -2), stunting (LAZ < -2), and microcephaly (HCAZ < -2), were compared between HEU and HUU. Correlates of growth faltering and poor growth were assessed using generalized Poisson and linear regression models. RESULTS: Among 2457 infants, 456 (19%) were HEU. Among mothers living with HIV, 64% received antiretroviral therapy (ART) and 22% were on antiretroviral prophylaxis during pregnancy. At 9 months, 72% of HEU and 98% of HUU were breastfeeding. At 6 weeks, HEU had lower mean WAZ (-0.41 vs. -0.09; P < 0.001) and LAZ (-0.99 vs. -0.31; P = 0.001) than HUU. Stunting was higher in HEU than HUU at 6 weeks (34% vs. 18%, P < 0.001) and 9 months (20% vs. 10%, P < 0.001). In multivariable analyses, HEU had lower mean LAZ at 6 weeks (-0.67, 95% confidence interval [CI]: -1.07, -0.26) and 9 months (-0.57, 95% CI: -0.92, -0.21) and HEU had higher stunting prevalence (week-6 adjusted prevalence ratio [aPR]: 1.88, 95% CI: 1.35, 2.63; month-9 aPR: 2.10, 95% CI: 1.41, 3.13). HEU had lower mean head circumference (-0.49, 95% CI: -0.91, -0.07) and higher prevalence of microcephaly (aPR: 2.21, 95% CI: 1.11, 4.41) at 9 months. CONCLUSION: Despite high maternal ART coverage, HEU had poorer growth than HUU in this large population-level comparison. Optimizing breastfeeding practices in HEU may be useful to improve growth.
Authors: Christine J McGrath; Benson Singa; Agnes Langat; John Kinuthia; Keshet Ronen; Danvers Omolo; Benjamin Elly Odongo; Rose Wafula; Prisca Muange; Abraham Katana; Lucy Ng'anga'; Grace C John-Stewart Journal: AIDS Care Date: 2017-11-11
Authors: Jamison Norwood; Megan Turner; Carmen Bofill; Peter Rebeiro; Bryan Shepherd; Sally Bebawy; Todd Hulgan; Stephen Raffanti; David W Haas; Timothy R Sterling; John R Koethe Journal: J Acquir Immune Defic Syndr Date: 2017-12-15 Impact factor: 3.731
Authors: Alana T Brennan; Rachael Bonawitz; Christopher J Gill; Donald M Thea; Mary Kleinman; Lawrence Long; Caitryn McCallum; Matthew P Fox Journal: J Acquir Immune Defic Syndr Date: 2019-09-01 Impact factor: 3.731
Authors: M Bulterys; A Chao; S Munyemana; J B Kurawige; P Nawrocki; P Habimana; M Kageruka; S Mukantabana; E Mbarutso; A Dushimimana Journal: Pediatr Infect Dis J Date: 1994-02 Impact factor: 2.129
Authors: Christopher R Sudfeld; Quanhong Lei; Yvonne Chinyanga; Esther Tumbare; Nealia Khan; Fredrick Dapaah-Siakwan; Abia Sebaka; Jacinta Sibiya; Erik van Widenfelt; Roger L Shapiro; Joseph Makhema; Wafaie W Fawzi; Kathleen M Powis Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Andrew J Prendergast; Bernard Chasekwa; Ceri Evans; Kuda Mutasa; Mduduzi N N Mbuya; Rebecca J Stoltzfus; Laura E Smith; Florence D Majo; Naume V Tavengwa; Batsirai Mutasa; Goldberg T Mangwadu; Cynthia M Chasokela; Ancikaria Chigumira; Lawrence H Moulton; Robert Ntozini; Jean H Humphrey Journal: Lancet Child Adolesc Health Date: 2018-12-18
Authors: Dorothy C Nyemba; Emma Kalk; Michael J Vinikoor; Hlengiwe P Madlala; Mwangelwa Mubiana-Mbewe; Maureen Mzumara; Carolyn Bolton Moore; Amy L Slogrove; Andrew Boulle; Mary-Ann Davies; Landon Myer; Kathleen Powis Journal: BMC Public Health Date: 2022-01-10 Impact factor: 4.135